Corbenic Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$130K Buy
253
+145
+134% +$72.8K 0.03% 50
2022
Q1
$55K Buy
108
+55
+104% +$26.5K 0.01% 75
2021
Q4
$27K Hold
53
0.01% 108
2021
Q3
$21K Buy
53
+8
+18% +$3.31K 0.01% 122
2021
Q2
$18K Hold
45
﹤0.01% 137
2021
Q1
$17K Hold
45
﹤0.01% 134
2020
Q4
$16K Hold
45
0.01% 112
2020
Q3
$14K Hold
45
0.01% 103
2020
Q2
$13K Sell
45
-25
-36% -$7.16K 0.01% 98
2020
Q1
$17K Sell
70
-242
-78% -$66.6K 0.01% 88
2019
Q4
$92K Buy
+312
New +$81.6K 0.07% 51
2017
Q4
$85K Sell
385
-22
-5% -$4.66K 0.11% 48
2017
Q3
$80K Buy
407
+22
+6% +$4.25K 0.11% 52
2017
Q2
$71K Hold
385
0.1% 53
2017
Q1
$63K Hold
385
0.08% 60
2016
Q4
$62K Hold
385
0.07% 63
2016
Q3
$54K Buy
+385
New +$53.9K 0.06% 69
2015
Q1
Sell
-45
Closed -$5K 212
2014
Q4
$5K Buy
+45
New +$4.26K ﹤0.01% 162

Other funds holding UNH

Corbenic Partners's UNH Position: Q2 2022 in Review

Corbenic Partners increased its UnitedHealth (UNH) stake by 134% in Q2 2022, buying an estimated $72.8K and bringing the position to 253 shares worth $130K. The position accounts for 0.03% of the portfolio, ranked #50.

Corbenic Partners first reported a position in UNH in Q4 2014 and has held it in 18 quarters since. 2,958 funds tracked by Wall St. Rank hold UNH as of Q2 2022.

  • Corbenic Partners held 253 shares of UnitedHealth worth $130K as of Q2 2022.
  • Corbenic Partners bought 145 UnitedHealth shares in Q2 2022, an estimated $72.8K.
  • UnitedHealth made up 0.03% of Corbenic Partners's portfolio in Q2 2022, its #50 holding.
  • Corbenic Partners first reported a position in UnitedHealth in Q4 2014 and has held it in 18 quarters since.
  • 2,958 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.